Nature Communications (Nov 2021)

Spatial and temporal intratumour heterogeneity has potential consequences for single biopsy-based neuroblastoma treatment decisions

  • Karin Schmelz,
  • Joern Toedling,
  • Matt Huska,
  • Maja C. Cwikla,
  • Louisa-Marie Kruetzfeldt,
  • Jutta Proba,
  • Peter F. Ambros,
  • Inge M. Ambros,
  • Sengül Boral,
  • Marco Lodrini,
  • Celine Y. Chen,
  • Martin Burkert,
  • Dennis Guergen,
  • Annabell Szymansky,
  • Kathy Astrahantseff,
  • Annette Kuenkele,
  • Kerstin Haase,
  • Matthias Fischer,
  • Hedwig E. Deubzer,
  • Falk Hertwig,
  • Patrick Hundsdoerfer,
  • Anton G. Henssen,
  • Roland F. Schwarz,
  • Johannes H. Schulte,
  • Angelika Eggert

DOI
https://doi.org/10.1038/s41467-021-26870-z
Journal volume & issue
Vol. 12, no. 1
pp. 1 – 13

Abstract

Read online

Neuroblastoma is a devastating tumour in children. Here, the authors analyse multi-region patient samples using genomics and transcriptomics, revealing temporal and spatial heterogeneity and questioning the reliability of single-biopsy based diagnostics.